Redox Mechanism in Infection-Associated Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 349
Special Issue Editor
Interests: cancer metabolism; metabolic rewiring; metabolomics; environmental stress; precision medicine; drugs effectiveness
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit a research or review article to a Special Issue entitled "Redox Mechanism in Infection-Associated Cancers".
Understanding the mechanisms by which genetic and environmental stressors drive the early events of carcinogenesis is critical to improving cancer prevention and cancer treatment. This Special Issue will focus on the mechanisms underlying the carcinogenic effects of infectious agents such as viruses and bacteria, with a particular emphasis on the redox-altering mechanisms of disease. The infectious agents may be those already recognized in cancer etiology (e.g., high-risk HPV, H. pylori) or infectious agents with suspected, but yet to be established, carcinogenic potential. Recognizing that genetic, demographic and lifestyle factors such as gender, age, ethnicity, diet, and exercise, or a combination of these, can shift the redox balance influencing the immune response to infections and, in turn, carcinogenesis, the articles submitted to this Special Issue may also explore the role of redox immunometabolism in infection-associated cancer. Lastly, we welcome articles investigating redox therapeutic approaches to prevention and treatment of infections and infection-associated cancers.
We look forward to your contribution.
Dr. Daniela Gaglio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- redox regulation
- cancer
- infectious agents
- intracellular pathogens
- carcinogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.